Sacubitril/valsartan, sodium‐glucose cotransporter 2 inhibitors and vericiguat for congestive heart failure therapy-Reference-Cited by-同舟云学术

Sacubitril/valsartan, sodium‐glucose cotransporter 2 inhibitors and vericiguat for congestive heart failure therapy

Published:2022-02-17 Issue:4 Volume:130 Page:425-438
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharma Tox

Author:

Norre Tobias¹,Grimm Daniela¹²,Simonsen Ulf¹^ORCID

Affiliation:

1. Department of Biomedicine Aarhus University Aarhus Denmark

2. Department of Microgravity and Translational Regenerative Medicine, Clinic for Plastic, Aesthetic and Hand Surgery Otto‐von‐Guericke‐University Magdeburg Magdeburg Germany

Funder

Novo Nordisk Fonden

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13714

Reference80 articles.

1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

3. Effects of Enalapril on Mortality in Severe Congestive Heart Failure

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sacubitril/valsartan ameliorates cardiac function and ventricular remodeling in CHF rats via the inhibition of the tryptophan/kynurenine metabolism and inflammation;Scientific Reports;2024-05-29

2. Efficacy of Sacubitril Valsartan sodium tablets in patients with heart failure combined with pulmonary infection and long-term recurrence rate;American Journal of Translational Research;2024

3. Determination of vericiguat in rat plasma by UPLC-MS/MS and its application to drug interaction;Journal of Chromatography A;2023-10

4. A Systematic Review of the Effect of Vericiguat on Patients with Heart Failure;International Journal of Molecular Sciences;2023-07-23

5. Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an overview of 36 systematic reviews;Heart Failure Reviews;2023-06-07